Table Of Contents
1 Introduction 26
1.1 Objectives Of The Study 26
1.2 Market Definition 26
1.3 Overview Of Global Transfection Reagents And Equipment Market 26
1.4 Currency And Pricing 27
1.5 Limitation 27
1.6 Markets Covered 28
2 Market Segmentation 30
2.1 Markets Covered 30
2.2 Geographic Scope 31
2.3 Years Considered For The Study 32
2.4 Currency And Pricing 32
2.5 Research Methodology 33
2.6 Primary Interviews With Key Opinion Leaders 36
2.7 The Category Vs Time Grid 37
2.8 Secondary Sources 40
2.9 Assumptions 40
3 Market Overview 41
3.1 Drivers 43
3.1.1 Rising Research Activities In Cell Science And Increase In Demand Of Chimeric Genes 43
3.1.2 Increasing R&D Spending And Research Activities By Pharmaceutical And Biotech Companies 44
3.1.3 Technological Advancements In Transfection Technology 45
3.1.4 Alliances Between The Leading Research Institutes To Trigger Drug Discovery 46
3.1.5 Rising Prevalence Of Chronic Indications 46
3.2 Restraints 48
3.2.1 Selective Effectiveness Of Transfection Reagents Or Instruments 48
3.2.2 High Cost Of Transfection Reagents And Equipment 48
3.2.3 Home Brew Reagents Limits The Sale Of Commercial Kits 50
3.3 Opportunities 51
3.3.1 Efficient Nuclear Delivery Method 51
3.3.2 Emerging Markets 51
3.4 Challenges 53
3.4.1 Slow Rate Of Transfection In Hard Cells 53
3.4.2 Cytotoxicity Effects Due To Transfection Reagents 53
4 Executive Summary 54
5 Premium Insights 57
6 Global Transfection Reagents And Equipment Market, By Product 60
6.1 Overview 61
6.2 Reagent 63
6.3 Equipment 64
7 Global Transfection Reagents And Equipment Market, By Method 65
7.1 Overview 66
7.2 Physical Method 68
7.2.1 Electroporation 69
7.2.2 Nucleofection 69
7.2.3 Others 69
7.2.3.1 Genegun 70
7.2.3.2 Magnetofection 70
7.2.3.3 Sonoporation 70
7.2.3.4 Optoinjection 70
7.3 Biochemical Methods 71
7.3.1 Lipofection 72
7.3.2 Calcium Phosphate 72
7.3.3 Deae-Dextran 72
7.3.4 Dendrimers 72
7.4 Viral Method 73
7.4.1 Retroviruses 74
7.4.2 Adenoviruses 74
7.4.3 Adenoassociated Viruses 74
7.4.4 Others 74
8 Global Transfection Reagents And Equipment Market, By Application 75
8.1 Overview 76
8.2 Protein Production 78
8.3 Biomedical Research 79
8.3.1 Gene Expression Studies 80
8.3.2 Cancer Research 80
8.3.3 Transgenic Models 80
8.4 Therapeutic Delivery 81
?
9 Global Transfection Reagents And Equipment Market, By End User 82
9.1 Overview 83
9.2 Academics & Research Institutes 85
9.3 Pharmaceutical & Biotechnology Companies 86
10 Global Transfection Reagents And Equipment, By Geography 87
10.1 Overview 88
10.2 North America 95
10.2.1 U.S. 105
10.2.2 Canada 110
10.2.3 Mexico 115
10.3 Europe 120
10.3.1 Germany 131
10.3.2 U.K. 136
10.3.3 France 141
10.3.4 Italy 146
10.3.5 Spain 151
10.3.6 Switzerland 156
10.3.7 Netherlands 161
10.3.8 Belgium 166
10.3.9 Russia 171
10.3.10 Turkey 176
10.3.11 Rest Of Europe 181
10.4 Asia-Pacific 182
10.4.1 China 193
10.4.2 Japan 198
10.4.3 South Korea 203
10.4.4 India 208
10.4.5 Singapore 213
10.4.6 Australia 218
10.4.7 Thailand 223
10.4.8 Malaysia 228
10.4.9 Indonesia 233
10.4.10 Philippines 238
10.4.11 Rest Of Asia-Pacific 243
10.5 South America 244
10.5.1 Brazil 254
10.5.2 Rest Of South America 259
?
10.6 Middle East And Africa 260
10.6.1 South Africa 270
10.6.2 Rest Of Middle East And Africa 275
11 Global Transfection Reagents And Equipment Market, Company Landscape 276
11.1 Company Share Analysis; Global 276
11.2 Company Share Analysis; North America 277
11.3 Company Share Analysis; Europe 278
11.4 Company Share Analysis; Asia-Pacific 279
12 Company Profile 280
12.1 Thermo Fisher Scientific Inc. 280
12.1.1 Company Overview 280
12.1.2 Revenue Analysis 280
12.1.3 Company Share Analysis 281
12.1.4 Product Portfolio 281
12.1.5 Recent Developments 282
12.2 Sigma-Aldrich, Inc. (Subsidiary Of Merck Kgaa) 283
12.2.1 Company Overview 283
12.2.2 Geographical Presence 283
12.2.3 Company Share Analysis 284
12.2.4 Product Portfolio 284
12.2.5 Recent Developments 284
12.3 Promega Corporation 285
12.3.1 Company Overview 285
12.3.2 Geographical Presence 285
12.3.3 Company Share Analysis 286
12.3.4 Product Portfolio 286
12.3.5 Recent Developments 286
12.4 Qiagen 287
12.4.1 Company Overview 287
12.4.2 Revenue Analysis 287
12.4.3 Company Share Analysis 288
12.4.4 Product Portfolio 288
12.4.5 Recent Developments 289
?
12.5 Bio-Rad Laboratories, Inc. 290
12.5.1 Company Overview 290
12.5.2 Revenue Analysis 290
12.5.3 Product Portfolio 291
12.5.4 Recent Developments 291
12.6 Genlantis Inc. 292
12.6.1 Company Overview 292
12.6.2 Geographical Presence 292
12.6.3 Product Portfolio 293
12.6.4 Recent Developments 293
12.7 Lonza 294
12.7.1 Company Overview 294
12.7.2 Revenue Analysis 294
12.7.3 Product Portfolio 295
12.7.4 Recent Developments 296
12.8 Maxcyte Inc 297
12.8.1 Company Overview 297
12.8.2 Geographical Presence 297
12.8.3 Product Portfolio 298
12.8.4 Recent Developments 298
12.9 Mirus Bio Llc 299
12.9.1 Company Overview 299
12.9.2 Geographical Presence 299
12.9.3 Product Portfolio 300
12.9.4 Recent Developments 301
12.10 Polyplus Transfection 302
12.10.1 Company Overview 302
12.10.2 Geographical Presence 302
12.10.3 Product Portfolio 303
12.10.4 Recent Developments 303
12.11 Signagen Laboratories. 304
12.11.1 Company Overview 304
12.11.2 Geographical Presence 304
12.11.3 Product Portfolio 305
12.11.4 Recent Development 305
13 Related Reports 306